InMed Pharmaceuticals Inc. (INM)
$1.33-2.21%Close
BUYRECOVERY · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 0.93
- P/E (TTM)
- -0.38
- Short % float
- 1.89%
- Days to cover
- 1.0
- SI change
- +114.7%
- 1W
- +0.00%
- 1M
- +2.31%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -0.20%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INM?
- LOPJLB’s latest quantitative signal on InMed Pharmaceuticals Inc. (INM) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is INM in?
- InMed Pharmaceuticals Inc. (INM) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does InMed Pharmaceuticals Inc. (INM) do?
- InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candid…